Colgate-Palmolive Company

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, PG has a market cap of 329.8B. Regarding current trading prices, CL is priced at $89.65, while PG trades at $142.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas PG's P/E ratio is 20.71. In terms of profitability, CL's ROE is +4.75%, compared to PG's ROE of +0.31%. Regarding short-term risk, CL is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check PG's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, UL has a market cap of 122.6B. Regarding current trading prices, CL is priced at $89.65, while UL trades at $57.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas UL's P/E ratio is 18.50. In terms of profitability, CL's ROE is +4.75%, compared to UL's ROE of +0.36%. Regarding short-term risk, CL is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check UL's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, KVUE has a market cap of 32.8B. Regarding current trading prices, CL is priced at $89.65, while KVUE trades at $17.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas KVUE's P/E ratio is 20.36. In terms of profitability, CL's ROE is +4.75%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, CL is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check KVUE's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, KMB has a market cap of 31.8B. Regarding current trading prices, CL is priced at $89.65, while KMB trades at $96.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas KMB's P/E ratio is 18.55. In terms of profitability, CL's ROE is +4.75%, compared to KMB's ROE of +1.44%. Regarding short-term risk, CL is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check KMB's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, EL has a market cap of 29B. Regarding current trading prices, CL is priced at $89.65, while EL trades at $80.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas EL's P/E ratio is -114.62. In terms of profitability, CL's ROE is +4.75%, compared to EL's ROE of -0.06%. Regarding short-term risk, CL is less volatile compared to EL. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check EL's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, CHD has a market cap of 22.3B. Regarding current trading prices, CL is priced at $89.65, while CHD trades at $96.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas CHD's P/E ratio is 30.94. In terms of profitability, CL's ROE is +4.75%, compared to CHD's ROE of +0.17%. Regarding short-term risk, CL is less volatile compared to CHD. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check CHD's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, SGI has a market cap of 13.2B. Regarding current trading prices, CL is priced at $89.65, while SGI trades at $63.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas SGI's P/E ratio is 25.08. In terms of profitability, CL's ROE is +4.75%, compared to SGI's ROE of +0.17%. Regarding short-term risk, CL is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check SGI's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, CLX has a market cap of 10.9B. Regarding current trading prices, CL is priced at $89.65, while CLX trades at $92.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas CLX's P/E ratio is 14.71. In terms of profitability, CL's ROE is +4.75%, compared to CLX's ROE of +28.26%. Regarding short-term risk, CL is less volatile compared to CLX. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check CLX's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, CL is priced at $89.65, while NTCO trades at $6.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas NTCO's P/E ratio is -11.37. In terms of profitability, CL's ROE is +4.75%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, CL is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check NTCO's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, ELF has a market cap of 3.3B. Regarding current trading prices, CL is priced at $89.65, while ELF trades at $55.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas ELF's P/E ratio is 31.88. In terms of profitability, CL's ROE is +4.75%, compared to ELF's ROE of +0.11%. Regarding short-term risk, CL is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check ELF's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, IPAR has a market cap of 2.8B. Regarding current trading prices, CL is priced at $89.65, while IPAR trades at $87.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas IPAR's P/E ratio is 16.35. In terms of profitability, CL's ROE is +4.75%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, CL is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check IPAR's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, COTY has a market cap of 1.8B. Regarding current trading prices, CL is priced at $89.65, while COTY trades at $2.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas COTY's P/E ratio is -3.31. In terms of profitability, CL's ROE is +4.75%, compared to COTY's ROE of -0.15%. Regarding short-term risk, CL is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check COTY's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, SPB has a market cap of 1.8B. Regarding current trading prices, CL is priced at $89.65, while SPB trades at $77.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas SPB's P/E ratio is 15.04. In terms of profitability, CL's ROE is +4.75%, compared to SPB's ROE of +0.07%. Regarding short-term risk, CL is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check SPB's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, NWL has a market cap of 1.6B. Regarding current trading prices, CL is priced at $89.65, while NWL trades at $3.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas NWL's P/E ratio is -5.73. In terms of profitability, CL's ROE is +4.75%, compared to NWL's ROE of -0.11%. Regarding short-term risk, CL is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check NWL's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, EPC has a market cap of 734.8M. Regarding current trading prices, CL is priced at $89.65, while EPC trades at $16.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas EPC's P/E ratio is -69.33. In terms of profitability, CL's ROE is +4.75%, compared to EPC's ROE of -0.05%. Regarding short-term risk, CL is less volatile compared to EPC. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check EPC's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, HELE has a market cap of 525.9M. Regarding current trading prices, CL is priced at $89.65, while HELE trades at $23.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas HELE's P/E ratio is -0.58. In terms of profitability, CL's ROE is +4.75%, compared to HELE's ROE of -0.95%. Regarding short-term risk, CL is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check HELE's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, CL is priced at $89.65, while EWCZ trades at $5.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, CL's ROE is +4.75%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, CL is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check EWCZ's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, NUS has a market cap of 297.6M. Regarding current trading prices, CL is priced at $89.65, while NUS trades at $6.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas NUS's P/E ratio is 5.68. In terms of profitability, CL's ROE is +4.75%, compared to NUS's ROE of +0.07%. Regarding short-term risk, CL is less volatile compared to NUS. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check NUS's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, CL is priced at $89.65, while PTNM trades at $10.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas PTNM's P/E ratio is 346.33. In terms of profitability, CL's ROE is +4.75%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, CL is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check PTNM's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, ACU has a market cap of 156.6M. Regarding current trading prices, CL is priced at $89.65, while ACU trades at $41.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas ACU's P/E ratio is 17.72. In terms of profitability, CL's ROE is +4.75%, compared to ACU's ROE of +0.08%. Regarding short-term risk, CL is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check ACU's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, SLSN has a market cap of 85.5M. Regarding current trading prices, CL is priced at $89.65, while SLSN trades at $1.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas SLSN's P/E ratio is 121.00. In terms of profitability, CL's ROE is +4.75%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, CL is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check SLSN's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, SKIN has a market cap of 83.4M. Regarding current trading prices, CL is priced at $89.65, while SKIN trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas SKIN's P/E ratio is -4.95. In terms of profitability, CL's ROE is +4.75%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, CL is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check SKIN's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, GROV has a market cap of 49.6M. Regarding current trading prices, CL is priced at $89.65, while GROV trades at $1.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas GROV's P/E ratio is -4.37. In terms of profitability, CL's ROE is +4.75%, compared to GROV's ROE of -1.06%. Regarding short-term risk, CL is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check GROV's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, AXIL has a market cap of 46.2M. Regarding current trading prices, CL is priced at $89.65, while AXIL trades at $6.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas AXIL's P/E ratio is 56.42. In terms of profitability, CL's ROE is +4.75%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, CL is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check AXIL's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, UG has a market cap of 32.9M. Regarding current trading prices, CL is priced at $89.65, while UG trades at $7.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas UG's P/E ratio is 13.77. In terms of profitability, CL's ROE is +4.75%, compared to UG's ROE of +0.21%. Regarding short-term risk, CL is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check UG's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, RAY has a market cap of 10.1M. Regarding current trading prices, CL is priced at $89.65, while RAY trades at $3.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas RAY's P/E ratio is 5.00. In terms of profitability, CL's ROE is +4.75%, compared to RAY's ROE of +0.09%. Regarding short-term risk, CL is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check RAY's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, PHH has a market cap of 10M. Regarding current trading prices, CL is priced at $89.65, while PHH trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas PHH's P/E ratio is -0.53. In terms of profitability, CL's ROE is +4.75%, compared to PHH's ROE of +0.38%. Regarding short-term risk, CL is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check PHH's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, DSY has a market cap of 9.6M. Regarding current trading prices, CL is priced at $89.65, while DSY trades at $2.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas DSY's P/E ratio is -0.23. In terms of profitability, CL's ROE is +4.75%, compared to DSY's ROE of +14.77%. Regarding short-term risk, CL is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check DSY's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, CL is priced at $89.65, while BRSH trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas BRSH's P/E ratio is -0.01. In terms of profitability, CL's ROE is +4.75%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, CL is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check BRSH's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, MTEX has a market cap of 8.6M. Regarding current trading prices, CL is priced at $89.65, while MTEX trades at $3.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas MTEX's P/E ratio is -0.56. In terms of profitability, CL's ROE is +4.75%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, CL is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check MTEX's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, TANH has a market cap of 2.6M. Regarding current trading prices, CL is priced at $89.65, while TANH trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas TANH's P/E ratio is -0.03. In terms of profitability, CL's ROE is +4.75%, compared to TANH's ROE of +0.04%. Regarding short-term risk, CL is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check TANH's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, DSYWW has a market cap of 1.1M. Regarding current trading prices, CL is priced at $89.65, while DSYWW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas DSYWW's P/E ratio is N/A. In terms of profitability, CL's ROE is +4.75%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, CL is less volatile compared to DSYWW. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check DSYWW's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, TKLF has a market cap of 905.8K. Regarding current trading prices, CL is priced at $89.65, while TKLF trades at $2.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas TKLF's P/E ratio is 1.95. In terms of profitability, CL's ROE is +4.75%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, CL is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check TKLF's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, CL is priced at $89.65, while BRSHW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas BRSHW's P/E ratio is N/A. In terms of profitability, CL's ROE is +4.75%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, CL is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check BRSHW's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, RDEN has a market cap of 0. Regarding current trading prices, CL is priced at $89.65, while RDEN trades at $13.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas RDEN's P/E ratio is N/A. In terms of profitability, CL's ROE is +4.75%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, CL is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check RDEN's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, REV has a market cap of 0. Regarding current trading prices, CL is priced at $89.65, while REV trades at $3.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas REV's P/E ratio is -1.19. In terms of profitability, CL's ROE is +4.75%, compared to REV's ROE of +0.89%. Regarding short-term risk, CL is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check REV's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, CL is priced at $89.65, while GROV-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, CL's ROE is +4.75%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, CL is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check GROV-WT's competition here

CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CL stands at 70.5B. In comparison, SUMR has a market cap of 0. Regarding current trading prices, CL is priced at $89.65, while SUMR trades at $11.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CL currently has a P/E ratio of 34.17, whereas SUMR's P/E ratio is -3.66. In terms of profitability, CL's ROE is +4.75%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, CL is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check SUMR's competition here